Expertise at Chang Gung System

Hsu, Sheng-Chieh ,Ph.D.
Institution: Chang Gung university
Position: Assistant Professor
Department: Department of Biomedical Sciences and Graduate Institute of Biomedical Sciences
Address: 259, Wen-Hwa 1st Rd., Kwei-Shan, Tao-Yuan, 333, Taiwan (R.O.C.)
Tel: +886-3-211-8800 # 3690 Fax: +886-3-211-8700
E-mail: schsu@mail.cgu.edu.tw

Focus of Interest:
  • Biochemistry and Molecular Biology – Medicine
  • Oncology

Fulltime Employment:
  • 3/2009 - Present Assistant Professor, Department of Biomedical Sciences, Chang Gung University, Taiwan

Education:
  • Ph.D. Institute of Microbiology and Immunology, National Yang-Ming University

Selected Main Publications:
  1. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. 2002 Mar. Hepatology 35:665-72.
  2. Lo HW, Hsu SC, Ali-Seyed M., Gunduz M, Xia W, Wei Y, Bartholomeusz G., Shih JY, Hung MC. Nuclear interaction of EGFR and STAT3 in the activation of iNOS/NO pathway. 2005 Jun. Cancer Cell 7(6):575-89.
  3. Hsu SC and Hung MC. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. 2007 Apr 6. J Biol. Chem. 282(14):10432-40.
  4. Hsu SC, Miller SA, Wang Y, Hung MC. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am. J. Transl. Res. 2009 Mar 8. 1(3):249-58.
  5. Wu CP, Sim HM, Huang YH, Liu YC, Hsiao SH, Cheng HW, Li YQ, Ambudkar SV, Hsu SC. 2013 Feb. Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochem Pharmacol. 85:325-334.


All Publications List

Board Certification:

  • American Association for Cancer Research